Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Keryx Biopharmaceuticals Inc. (KERX)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on KERX
Newest on KERX
VFC's Stock House
(1)
Michael Becker
(1)
Market Folly
(1)
MidnightTrader.com
(1)
Douglas Krohn
(1)
Most frequent on KERX
Alan Brochstein
(
6
)
Davy Bui
(
2
)
Shlomo Greenberg
(
2
)
Michael Becker
(
1
)
Market Folly
(
1
)
Most followed on KERX
Bespoke Investment Group
(
2221
)
Mike Havrilla
(
1125
)
Market Folly
(
1092
)
Alan Brochstein
(
537
)
Davy Bui
(
299
)
Most commented on KERX
Alan Brochstein
(
16
)
MidnightTrader.com
(
8
)
VFC's Stock House
(
8
)
Michael Becker
(
5
)
Davy Bui
(
3
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Keryx Biopharmaceuticals Inc. (KERX)
by
latest
|
most commented
6 More Stock Briefs
Jun 25
•
VFC's Stock House
•
CSUH.OB
,
C
,
CRYP
•
8 Comments
|
Quick Read
FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
Jun 9
•
Mike Havrilla
•
DYAX
,
ARNA
,
GSK
•
Comment!
|
Quick Read
Monday's Closing Update
Jun 8
•
MidnightTrader.com
•
ALL
,
BCS
,
AAPL
•
8 Comments
|
Quick Read
Keryx: Another Beneficiary of the ASCO Effect
Jun 3
•
Michael Becker
•
AEZS
,
KERX
,
EXEL
•
5 Comments
|
Quick Read
Klarman, Witmer & Einhorn: Examining 2009 Q1 13F Filings
May 19
•
Davy Bui
•
BBEP
,
CNW
,
CF
•
2 Comments
|
Quick Read
SAC Capital Portfolio Update: 37 13G Filings
Jan 15
•
Market Folly
•
AERG
,
AGO
,
ACOR
•
Comment!
|
Quick Read
Best and Worst Performing Stocks in the Russell 3,000 Year to Date
Jun 13, 2008
•
Bespoke Investment Group
•
ANR
,
THMR.PK
,
ABK
•
2 Comments
|
Quick Read
Latest Peek Inside the Portfolios of Klarman, Witmer, Third Ave.
May 19, 2008
•
Davy Bui
•
EEV
,
AEO
,
FXP
•
1 Comment
|
Quick Read
The Best and Worst Performing Stocks in the U.S.
Apr 24, 2008
•
TickerSense
•
AMPX
,
AGIX
,
ABK
•
2 Comments
|
Quick Read
Sulonex from Keryx: Unlikely Phase III Success
Feb 27, 2008
•
Douglas Krohn
•
KERX
•
2 Comments
|
Quick Read
Cancer Stocks: Lagging Again
Jul 16, 2007
•
Alan Brochstein
•
AMGN
,
ACEL
,
AFFY
•
1 Comment
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Protalix BioTherapeutics: This Dream Could Take Time to Manifest
Apr 13, 2007
•
Shlomo Greenberg
•
ELOS
,
ECIL
,
ELRN
•
1 Comment
|
Quick Read
Does Keryx Biopharmaceuticals Deserve Its Valuation?
Oct 19, 2006
•
Shlomo Greenberg
•
KERX
,
TEVA
•
Comment!
|
Quick Read